Creekmur Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.39M Buy
18,963
+2,884
+18% +$587K 0.73% 24
2025
Q2
$2.98M Buy
16,079
+6,072
+61% +$1.13M 0.53% 28
2025
Q1
$2.1M Buy
10,007
+1,304
+15% +$254K 0.44% 24
2024
Q4
$1.55M Sell
8,703
-3,961
-31% -$728K 0.35% 35
2024
Q3
$2.5M Buy
12,664
+2,188
+21% +$408K 0.59% 25
2024
Q2
$1.8M Buy
10,476
+1,704
+19% +$282K 0.46% 29
2024
Q1
$1.6M Buy
8,772
+337
+4% +$58.1K 0.55% 28
2023
Q4
$1.31M Buy
+8,435
New +$1.23M 0.41% 36

Other funds holding ABBV

Creekmur Asset Management's ABBV Position: Q3 2025 in Review

Creekmur Asset Management increased its AbbVie (ABBV) stake by 18% in Q3 2025, buying an estimated $587K and bringing the position to 18,963 shares worth $4.39M. The position accounts for 0.73% of the portfolio, ranked #24.

Creekmur Asset Management first reported a position in ABBV in Q4 2023 and has held it in 8 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Creekmur Asset Management held 18,963 shares of AbbVie worth $4.39M as of Q3 2025.
  • Creekmur Asset Management bought 2,884 AbbVie shares in Q3 2025, an estimated $587K.
  • AbbVie made up 0.73% of Creekmur Asset Management's portfolio in Q3 2025, its #24 holding.
  • Creekmur Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 8 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.